# Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac

> **NCT05558150** · PHASE1 · COMPLETED · sponsor: **Il-Yang Pharm. Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Drug Interaction Potentiation

## Interventions

- **DRUG:** Ilaprazole
- **DRUG:** Aceclofenac

## Key facts

- **NCT ID:** NCT05558150
- **Lead sponsor:** Il-Yang Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-10
- **Primary completion:** 2022-12-14
- **Final completion:** 2022-12-22
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05558150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05558150, "Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05558150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*